Pierluigi Antonelli

Corporate Officer/Principal chez FRESENIUS SE & CO. KGAA

Health Technology

Consumer Services

Finance

Profil

Currently, Pierluigi Antonelli is Chief Executive Officer-Fresenius Kabi at Fresenius SE & Co. KGaA since 2023, Chairman & President, Chief Executive Officer at Fresenius Kabi AG, and Chief Executive Officer at Fresenius Kabi.
Formerly, Mr. Antonelli was Chief Executive Officer at Angelini Pharma Italia Aziende Chimiche Riunite Angelini Franc and Angelini Pharma, Inc., Chief Executive Officer at Angelini Pharma SpA from 2019 to 2023, European Vice President & Managing Director-Italy at Bristol-Myers Squibb GmbH & Co. KGaA, Head-Europe Novartis Oncology at Sandoz Deutschland GmbH from 2015 to 2019, Engagement Manager at Mckinsey & Co., Inc. (Munich) from 1994 to 1998, and Senior Vice President-Italy at Merck & Co. Education includes an MBA from Northwestern University in 1994 and an undergraduate degree from The LUISS University of Rome in 1989.

Postes actifs de Pierluigi Antonelli

Sociétés	Poste	Début
FRESENIUS SE & CO. KGAA	Corporate Officer/Principal	01/03/2023
Fresenius Kabi AG Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases	Directeur Général	-
Fresenius Kabi	Directeur Général	-

Tous les postes actifs de Pierluigi Antonelli

Anciens postes connus de Pierluigi Antonelli

Sociétés	Poste	Fin
Angelini Pharma SpA Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs	Directeur Général	06/02/2023
Sandoz Deutschland GmbH Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company	Corporate Officer/Principal	01/01/2019
Mckinsey & Co., Inc. (Munich)	Corporate Officer/Principal	01/01/1998
Bristol-Myers Squibb GmbH & Co. KGaA Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines	Corporate Officer/Principal	-
Merck & Co. Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings	Corporate Officer/Principal	-

Voir l'expérience en détail de Pierluigi Antonelli

Formation de Pierluigi Antonelli

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Pierluigi Antonelli

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	12
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices	Health Services
Fresenius Kabi AG Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases	Health Technology
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Northwestern University Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The LUISS University of Rome The LUISS University of Rome Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fresenius Kabi
Sandoz Deutschland GmbH Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company	Finance
Bristol-Myers Squibb GmbH & Co. KGaA Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines	Health Technology
Mckinsey & Co., Inc. (Munich)
Angelini Pharma, Inc. Angelini Pharma, Inc. Specialty StoresRetail Trade Operates as a medical supply store	Retail Trade
Merck & Co. Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings	Finance
Angelini Pharma SpA Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs	Health Technology